Profilo
Nick DeLong is the founder of Evolved Capital, Inc. He previously worked as the Head of Business Development at Tris Pharma, Inc. and as the Vice President of Corporate Development at iBio, Inc. He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers University- Newark.
Precedenti posizioni note di Nick DeLong
| Società | Posizione | Fine |
|---|---|---|
| IBIO, INC. | Corporate Officer/Principal | 01/06/2024 |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Fondatore | - |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Corporate Officer/Principal | - |
Formazione di Nick DeLong
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Rutgers University- Newark
Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Technology Services |
















